Story perspectives

Weight-Loss Surgery Outperforms GLP-1 Drugs in Long-Term Health

9/21/2025

Summary

Story summary

A study shows weight-loss surgery provides more significant long-term health benefits than GLP-1 drugs for obesity and type 2 diabetes patients.
Surgery participants lost about 22% of their body weight over ten years, while GLP-1 users lost 6.8%.
Surgery reduced serious cardiac events by 35% and lowered advanced kidney disease and eye damage risks by 47% and 54%.
Tracking nearly 4,000 patients, the study found a 32% lower risk of death in the surgery group after ten years.
Researchers call for future trials to compare surgery with newer GLP-1 drugs.

1 of 1

Story summary

A study shows weight-loss surgery provides more significant long-term health benefits than GLP-1 drugs for obesity and type 2 diabetes patients.
Surgery participants lost about 22% of their body weight over ten years, while GLP-1 users lost 6.8%.
Surgery reduced serious cardiac events by 35% and lowered advanced kidney disease and eye damage risks by 47% and 54%.
Tracking nearly 4,000 patients, the study found a 32% lower risk of death in the surgery group after ten years.
Researchers call for future trials to compare surgery with newer GLP-1 drugs.